Search

Your search keyword '"Lanza, A. Galeota"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Lanza, A. Galeota" Remove constraint Author: "Lanza, A. Galeota"
118 results on '"Lanza, A. Galeota"'

Search Results

1. Trends in liver transplantation for primary sclerosing cholangitis

2. Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence

4. Trends in liver transplantation for primary sclerosing cholangitis.

6. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: Risk of HCC recurrence from a large, multicentre retrospective study from Italy

7. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy

8. Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy

9. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

10. Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy

11. Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti–Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation

15. Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients

16. The IMPROVEMENT project: first report of the global liver transplant activity

19. Covid-19 in Liver Transplant Recipients: An Italian Case-Control Double-Centre Study.

22. Pregnancy after liver transplantation: a survey from Italian liver transplants centres

23. THU-527 - Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy

24. OS-069 - Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy

25. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

31. P.04.14 HEPATOCELLULAR CARCINOMA AND SMOKING ARE INDEPENDENT RISK FACTORS FOR DEVELOPMENT OF DE-NOVO EXTRAHEPATIC TUMORS IN LIVER TRANSPLANT RECIPIENTS

36. Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment

37. Linee di Gestione per l'immunosoppressione nel paziente adulto trapiantato di fegato - Aggiornamento 2022: Percorso delle attività dei Gruppi di Lavoro e raggiungimento del Consenso da parte del Panel di Esperti dei Centri Italiani.

38. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

39. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

40. Sa1872 Biomolecolar Markers Fail to Assist the Prognostic Evaluation of Hepatocellular Carcinoma

Catalog

Books, media, physical & digital resources